Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Leiomyoma 2Polyps 1Agnosia 1

Interventions

Cyclophosphamide 910Carboplatin 787pembrolizumab 746Paclitaxel 744Bevacizumab 716Cisplatin 708Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 338Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Uterine Myomectomy × Clear all
NCT00730886 2018-08-15

ExAblate Treatment of Uterine Fibroids for Fertility Enhancement

InSightec

Phase NA Terminated
2 enrolled 6 charts

Leiomyoma

NCT01152112 2017-09-13

HOME

Hologic, Inc.

Phase NA Completed
74 enrolled 5 charts

Agnosia, Leiomyoma, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡